INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2015

Higher circulating 25-hydroxyvitamin D concentrations at diagnosis were linked to longer survival in women with ovarian cancer.

Researchers evaluated serum 25(OH)D concentrations in women with invasive ovarian cancer at diagnosis (n = 670) or after primary treatment (n = 336) and tracked survival via medical records and the Australian National Death Index. Overall, 59% of the women died during follow-up, with 95% of deaths due to ovarian cancer. Higher 25(OH)D levels at diagnosis were significantly associated with longer survival (adjusted HR: 0.93; 95% CI: 0.88, 0.99 per 10 nmol/L). However, no significant association was observed for progression-free survival or for 25(OH)D measured after primary treatment.

Shows an association, not proof of cause and effect.

Study type
Prospective cohort study
Who was studied
Women with invasive ovarian cancer from the Australian Ovarian Cancer Study (n=670 at diagnosis, n=336 post-treatment)
What was measured
Overall survival and progression-free survival

THE PAPER

Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer.

Webb PM, de Fazio A, Protani MM, Ibiebele TI, Nagle CM, Brand AH, Blomfield PI, Grant P, Perrin LC, Neale RE, Australian Ovarian Cancer Study Group. Am J Clin Nutr, 2015.

PubMed 25971716 ↗DOI 10.3945/ajcn.114.102681 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.